Skip to main
NGVT

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp's management has demonstrated a commitment to enhancing the company's portfolio through strategic asset sales, which are expected to improve overall operational efficiency. This execution is anticipated to reduce earnings volatility while simultaneously advancing the margin profile of the business, thus positively influencing financial performance. Overall, these strategic measures position Ingevity for potential revenue growth, reflecting optimism about the company's future financial prospects.

Bears say

Ingevity Corp faces significant risks that could negatively impact its financial performance, particularly if there is a downturn in global auto production, which could hinder the company's ability to transition its customer base toward Alternative Fuel Applications (AFA). The company's reliance on its Performance Materials segment, which is highly dependent on the automotive industry, combined with potential margin pressures from various external factors such as tariffs and new market entrants, casts doubt on future earnings stability. Additionally, the reliance on high transaction multiples relative to expected EBITDA might not be sustainable, further contributing to a concerning outlook for Ingevity's stock.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Dec 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $65, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $65, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.